Fig. 3.
Overall survival for the 188 patients, regardless of being resected or not, receiving chemotherapy stratified by resectability status (borderline resectable versus locally advanced) according to the National Comprehensive Cancer Network classification
BRPC, borderline resectable pancreatic cancer; LAPC, locally advanced pancreatic cancer.